HC Wainwright reiterated their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price objective on the stock. Separately, Bloom Burton lowered Repare Therapeutics from a buy rating to an accumulate rating in a research […]
Related Keywords
United States , Canada , America , , America Corp , Blue Owl Capital Holdings , Investment Management , Repare Therapeutics Inc , Versant Venture Management , Repare Therapeutics Company Profile , Repare Therapeutics , Free Report , Bloom Burton , Moderate Buy , Owl Capital Holdings , Venture Management , Get Free Report , Therapeutics Inc , Repare Therapeutics Daily , Nasdaq Rptx , Rptx , Medical , Reiterated Rating , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.